Key result
Gemcitabine-docetaxel yields stable disease after progression on epirubicin-ifosfamide in a cardiac sarcoma case.
Why the study?
Pulmonary artery sarcoma is an aggressive tumour whose clinical presentation may resemble pulmonary embolism, making prompt diagnosis necessary to improve survival.
Case Report (n=1)
Pulmonary artery sarcoma is an aggressive tumor that mimics pulmonary embolism and requires high clinical suspicion and advanced imaging for prompt diagnosis.
Answers are grounded in this paper and cite their sources.
Gemcitabine-docetaxel may stabilize pulmonary artery sarcoma after epirubicin-ifosfamide progression; hypothesis-generating and should not yet change practice.
Pulmonary artery sarcoma is an aggressive tumour that originates from the intimal layer of the pulmonary trunk and pulmonary arteries. Clinical presentation may resemble a pulmonary embolism. Prompt diagnosis is necessary to improve survival.https://bit.ly/2xZwENm
No takes yet. Share an insight, caveat, or question.
Cervilla‐Muñoz et al. (2020) conducted a case report in Pulmonary artery sarcoma (n=1). Cytoreductive chemotherapy (epirubicin plus ifosfamide, followed by gemcitabine-docetaxel) was evaluated on Clinical response to chemotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: